Congrats to SIC portfolio company Voyage Foods on its $52M Series A and exclusive distribution partnership with Cargill.

      Congrats to SIC portfolio company Voyage Foods on its $52M Series A and exclusive distribution partnership with Cargill.

      Congrats to SIC portfolio company Voyage Foods on its $52M Series A and exclusive distribution partnership with Cargill.

      Congrats to SIC portfolio company Voyage Foods on its $52M Series A and exclusive distribution partnership with Cargill.

    open menu
      Investments Team Press Social Proof Contact
      home
      LPs
    home CLOSE
      Investments
      Team
      Press
      Social Proof
      Contact
      LPs

    FILTER BY SECTOR

    CLOSE
      All Sectors 0
      Biotech 0
      Deeptech 0
      Consumer 0
      B2B 0
      Fintech 0
      Healthtech 0
      Blockchain 0

    FILTER BY PARTNER

    CLOSE
      All Partners 0
      Sarah Cone 0
      Jason Paragas 0
      Justin Stebbing 0
      Ashby Monk 0
      Aaron Hurst 0
      Chinmaya Rath 0
      Raji Baskaran 0
      Sean Rad 0
      Will Manidis 0
      Stephen Wolfram 0
      Kathleen Breitman 0
      Emin Gun Sirer 0
      Nik Sharma 0
      Carson Kahn 0
      Benjamin Chesler 0
      Ryan Bethencourt 0

    FILTER BY STAGE

    CLOSE
      All Companies 0
      Series B 0
      Seed 0
      Series A 0
      Unicorns 0
      Exited 0
      Pre-Seed 0
      Closed 0

    FILTER BY IMPACT

    CLOSE
      All Impacts 0
      Health & Safety 0
      Environment 0
      Social Systems 0
      Supply Chains 0
      Food Systems 0

    FILTER BY FUNDS

    CLOSE
      All Funds 0
      Fund 1 0
      SPVs 0

    FILTER BY NETWORK

    CLOSE
      All Networks 0
      DCVC 0
      Flagship Pioneering 0
      DARPA 0
      Lawrence Livermore Lab 0
      Ichan School of Medicine at Mt. Sinai 0
      Harvard Medical School 0
      MIT 0
      National Academy of Engineering 0
      National Academy of Sciences 0
      World Economic Forum 0
      Founders Fund 0
      Ginkgo Bioworks 0
      National Academies of Sciences 0
      Tinder 0
      USC 0
      Institute for Advanced Study 0
      American Mathematical Society 0
      Caltech 0
      Oxford 0
      Novartis 0
      AstraZeneca 0
      Glycomimetics 0
      Material Innovation Institute 0
      Georgetown 0
      The Good Food Institute 0
      The Humane Society 0
      Animal Legal Defense Fund 0
      Federal Reserve 0
      ECB 0
      Columbia University 0
      New York University 0
      KPMG 0
      Imperial College 0
      Anglia Ruskin University 0
      Cornell 0
      Initiative for Cryptocurrencies and Smart Contracts 0
      Microsoft 0
      University of Washington 0
      Duke University 0
      World Bank 0
      23andMe Alumni 0
      Verily 0
      Rock Health 0
      Stanford Medical School 0
      Google 0
      Stanford 0
      McKinsey 0
      Wharton 0
      Veradigm 0
      Thiel Foundation 0
      Dorm Room Fund 0
      US Navy 0
      Lyft 0
      Georgetown University 0
      PwC 0
      Walmart 0
      Bloomberg 0
      JP Morgan 0
      University of Virginia 0
      The Wall Street Journal 0
      Tezos 0
      VaynerX 0
      Sharma Brands 0
      SALT 0
      Lux Capital 0
      Not Boring 0
      Stanford University 0
      UC Berkeley 0
      NYU 0
      Y Combinator 0
      Intel 0
      IFC 0
      IIT 0
      University of Michigan 0
      Amazon 0
      University of Colorado 0
      UCSC 0
      University of Oxford 0
      Harvard University 0
      University of Chicago 0
      Carnegie Mellon 0
      National Academy of Science 0
      Green Building Alliance 0
      USGBC 0
      Northeastern University 0
      Brown University 0
      Hollywood 0
      Imperial College London 0
      Cambridge University 0
      Oxford University 0
      Pearson 0
      Kauffman Fellows 0
      University of Cambridge 0
      IndieBio 0
      SpaceX 0
      Apple 0
      Harvard 0
      Bird 0
      CIO Strategy Exchange 0
      Spotify 0
      Spin 0
      Buoy 0
      Dakai 0
      InnovateUK 0
      Equidam 0
      Hustle Fund 0
      HSBC 0
      Uber 0
      Northwestern Kellogg 0
      BCG 0
      The Wharton School 0
      Realterm 0
      British International Investment 0

    FILTER BY DOMAIN

    CLOSE
      All Domains 0
      Healthcare 0
      Biotech 0
      Deeptech 0
      Frontier Tech 0
      Vaccines 0
      Microbiology 0
      Genetics 0
      Genome Sequencing 0
      DNA Assembly 0
      Synthetic Biology 0
      Neurotechnology 0
      Organoids 0
      Gene Therapy 0
      Aging Reversal 0
      Machine Learning for Protein Engineering 0
      Nuclear 0
      Policy 0
      Computational Biology 0
      Artificial Intelligence 0
      Biosecurity 0
      Social Media 0
      Technology 0
      Mathematics 0
      Theoretical Physics 0
      Enterprise Software 0
      Complex Systems 0
      Cell Therapy 0
      Oncology 0
      Small Molecules 0
      Animal Rights 0
      Sustainability 0
      NGOs 0
      Material Science 0
      Fintech 0
      Industrials 0
      Commodities 0
      Insurance 0
      Immunology 0
      Clinical Trials 0
      Treating Cancer Patients 0
      Blockchain 0
      Computer Science 0
      Distributed Systems 0
      Water 0
      Climate Resiliency 0
      Public Utilities 0
      Alzheimer’s Disease 0
      Health Data 0
      Life Sciences 0
      Information Theory 0
      Page Rank 0
      Machine Learning 0
      Pharmaceuticals 0
      Medical Devices 0
      Medtech 0
      Urban Mobility 0
      Climate Tech 0
      Marketplaces 0
      Transporation 0
      Corporate Data 0
      Capital Markets 0
      Smart Contracts 0
      Cryptocurrencies 0
      Peer-to-Peer Networks 0
      ICOs 0
      Consumer 0
      Brands 0
      DTC 0
      Psychedelics 0
      Mental Health 0
      Suicide 0
      Psychology 0
      Hardware 0
      Cooking 0
      Data Science 0
      Social Enterprises 0
      Pension Funds 0
      Social Impact Investing 0
      Academics 0
      Architecture 0
      Food Retail 0
      Produce 0
      Supplements 0
      African VC & Startups 0
      Brain Research 0
      Neuroscience 0
      Impact Investing 0
      ESG 0
      Edtech 0
      Public Sector 0
      Food Systems 0
      Vegan Food 0
      Cellular Agriculture 0
      Energy 0
      Aerospace 0
      Artificial intelligence 0
      Long Term Investing 0
      CIOs 0
      Sustainability Executives 0
      Changemakers 0
      Computer Infrastructure 0
      SaaS 0
      Cryptocurrency 0
      Digital Media 0
      Semiconductors 0
      Quantum Computing 0
      Finance 0
      Real Estate 0

    FILTER BY SKILlS

    CLOSE
      All Skills 0
      Biotech Strategy 0
      Healthcare Innovation 0
      Founder 0
      Scientific Research 0
      Technology Transfer 0
      DNA Synthesis 0
      Tissue Reprogramming 0
      Government Relations 0
      Protein Design 0
      Business Development 0
      Microbial Engineering 0
      Entrepreneurship 0
      VC 0
      Unicorns 0
      Algorithms 0
      Mathematics 0
      Physics 0
      Pharma Partnerships 0
      Pharma Business Development 0
      Pharma Marketing 0
      Pharma M&A 0
      Litigation 0
      International Engagement 0
      Corporate Law 0
      Macroeconomics 0
      Executive Leadership 0
      Capital Markets 0
      Investing 0
      Research 0
      Scientific Collaboration 0
      Router 0
      Medicine 0
      Computer Networking 0
      Operating Systems 0
      Peer-to-Peer Systems 0
      Unicorn 0
      Policy 0
      Corporate Sustainability 0
      Public Utilities 0
      Rocketship 0
      Patents 0
      Strategy in Life Sciences 0
      Translational Medicine 0
      Software Engineering 0
      Distributed Systems 0
      Hedge Funds 0
      Circuit Design 0
      M&A 0
      Artificial Intelligence 0
      Scalability 0
      Cloud Computing 0
      Machine Learning 0
      C++ 0
      Strategic Partnerships 0
      Data Analysis 0
      LLMs 0
      Operations 0
      Marketing 0
      Investment Banking 0
      Acquisitions 0
      Corporate Data 0
      DTC 0
      Brand Launches 0
      Creative Strategy 0
      Retention Strategy 0
      Channel Expansion 0
      Conversion Rate Optimization Influencer Marketing 0
      Alcohol Branding 0
      Writing 0
      Deeptech VC 0
      Storytelling 0
      Consumer Hardware 0
      Call Centers 0
      Psychology 0
      Appearing on Shark Tank 0
      Hardware Development 0
      Large Language Models 0
      Software Development 0
      Sensor Enabled Systems 0
      Integrated Circuits 0
      Coaching 0
      B Corps 0
      Software Products 0
      Economics 0
      Consulting 0
      Environmental Design 0
      Workplace Performance Design 0
      Angel Investing 0
      Electrical Engineering 0
      Hardware Engineering 0
      Neuroscience 0
      Education 0
      Angel Investor 0
      CPG 0
      Strategic Decision Making 0
      Customer Surveys 0
      Customer Engagement 0
      Product Development 0
      System Architecture 0
      CIO Strategy Exchange 0
      Valuation 0
      Sourcing & screening 0
      Angel investing 0
      Go-to-Market Strategy 0
      Fundraising 0
      Financial Analysis 0
      Business Strategy 0
  CLOSE

  We’d love to learn more about you.

      I am a LP
      I am an entrepreneur
      I am a friend of the firm
      I am a VC
    SUBMIT

  Thank you for joining our newsletter

            ...

            WE INVEST IN FOUNDERS IMPACTING HISTORY

            scroll down

          We believe in Khosla's Instigator Hypothesis: individuals scaling world-changing technology will solve the largest problems in the world. For example, 12-15 entrepreneurs creating the right companies is all it will take to solve the climate crisis.

          We are a research-driven venture capital firm that invests as early as possible into the “best ideas in impact.” Too much of venture capital has gone into “backyard problems” rather than the grand global challenges.

          We exist to fund and support founders working on the hardest problems in the world.

          We are the earliest investors in mission-driven founders until their companies are attractive to top-tier VCs. In our Fund I, we have a 69% rate of follow-on investment by top-tier firms and a 100% follow-on rate overall.

          AS OF Q4 2024

          Our investments

              Totus Medicines

              Platform to rapidly design covalent drugs and cure new illnesses.

                We invested Pre-Seed
                Last round Series B led by DCVC Bio

              Limelight Steel

              Harnessing light to power zero-emissions steel manufacturing.

                We invested Pre-Seed
                Last round Seed led by Khosla

              Charm Industrial

              Converts waste biomass into fast pyrolysis, high carbon bio-oil.

                We invested Series A
                Last round Series B led by General Catalyst

              Voyage Foods

              Future-proofing your favorite food and drink.

                We invested Seed
                Last round Series A led by Horizons

              Prometheus Fuels

              Removes CO2 and turns it into carbon-zero gasoline, diesel, and jet fuel.

                We invested Pre-Seed
                Last round Unicorn Series B led by Maersk

              Quell

              World-leading fitness gaming company.

                We invested Pre-Seed
                Last round Seed led by Khosla
          See all 45 Investments

          WE AIM TO BE THE MOST COLLABORATIVE FUND IN THE WORLD.

          REACH OUT

          Our team invests worldwide from NYC

            We partner early. We are comfortable with the rough imperfections of start-ups. As a solo GP with 42+ venture partners, we are highly responsive but also have the broad-based experience to fully support world-changing entrepreneurs.

              Sarah Cone

              Founder & Managing Partner

            Plus 42 global venture partners that help founders bend the trajectory of success

              SEE FULL TEAM

            Social Proof

          We could talk about ourselves but it’s better to hear it from others.

              Jason Pontin

              GP, DCVC

              Sarah’s superpower is plunging obsessively into the data on the most difficult social impact problems, and coming up with novel and creative ways to solve them building venture-backable, future billion-dollar companies.

              Jason was formerly a Venture Partner at SIC.

              Peter Levine

              GP, Andreessen Horowitz

              When studying social impact models for our family foundation, we kept hearing Social Impact Capital's work was the gold standard.

              Peter is a part of the SIC network.

              Carson Kahn

              CPO & Co-Founder, Spindle AI

              I’m consistently impressed with the intellectual rigor of the talent that Sarah Cone and her network attract. Their recruiting superpower is a perpetual motion machine: rare, compounding, and uniquely formidable.

              Carson Kahn is an SIC Venture Partner, and a repeat founder.

              Peter Thiel

              Founder, Thiel Capital

              If there’s going to be a future at all, we have to build it, and Social Impact Capital is on the forefront of financing it ... Sarah Cone is a terrific investor that I’ve been happy to work with ... Sarah just really, really does the work ... She excels at identifying breakthrough technologies and mission-oriented companies that will go on to build the 21st century future that has been held at bay for 20 years ... Sarah is tracking the early stages of building a top-tier VC firm.

              Peter is an LP in SIC Fund I.

          Latest Press

          Supply chains in chaos? These 5 startups turn waste into opportunity

          Forbes April 10, 2025

          Marco Lobba and Sophia Lugo named to San Francisco Business Times 40 under 40

          San Francisco Business Times April 5, 2025

          Indian tech company Praan's new smart air purifier is (literally) a breath of fresh air

          Homegrown March 31, 2025

          Carbon capture or how to close the loop

          BBVA March 27, 2025

          4 technologies that could power the future of energy

          MIT Technology Review March 19, 2025

              Incorrect mail format

              SUBSCRIBE

            Social Impact Capital

            © All rights reserved 2023

              LPs
          Investments Team Press Social Proof Contact

            Investing worldwide from NYC

            Socials:

              twitter instagram linkedin

          Social Impact Capital

          © All rights reserved 2023